MPLN
Overvalued by 109.1% based on the discounted cash flow analysis.
Market cap | $455.41 Million |
---|---|
Enterprise Value | $4.94 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.14 |
Beta | 0.0 |
Outstanding Shares | 644,868,398 |
Avg 30 Day Volume | 2,719,191 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -4.97 |
---|---|
PEG | 0.0 |
Price to Sales | 0.6 |
Price to Book Ratio | 0.6 |
Enterprise Value to Revenue | 5.15 |
Enterprise Value to EBIT | 33.47 |
Enterprise Value to Net Income | -8 |
Total Debt to Enterprise | 0.92 |
Debt to Equity | 3.88 |
No data
No data
MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPl...